Back to Top Skip to main content Skip to sub-navigation

MHS ensures vaccine safety with immunization health care specialists

Military personnel, wearing a mask, looking at a syringe and a vial. Navy Hospital Corpsman 2nd Class Desiree Gee prepares a syringe with the influenza vaccine before administering annual flu shots at Navy Medicine Readiness and Training Command Corpus Christi, Texas. (Photo by Dale Davis.)

Recommended Content:

Immunization Healthcare | Vaccine Storage and Handling

Overseeing the quality control of vaccines throughout the Military Health System falls on immunization healthcare specialists (IHS) within the Defense Health Agency’s Immunization Healthcare Division. A total of 17 IHSs are spread throughout the four regional vaccine safety hubs, covering the North Atlantic, South Atlantic, Central, and Pacific regions. In addition to the regional hubs, the IHSs also support the Combatant Commands. They assist burdened immunization staffs to help streamline processes and provide guidance on the latest protocols on immunization safety.

“Most of the immunizers are young troops and they want to do the right thing and to be the person they can reach out to and get an answer or get some reassurance, for me personally is extremely rewarding,” said Bill Jones, immunization health care specialist with the Central Region Vaccine Safety Hub.

Fellow IHS Don Dutra of the North Atlantic Region Vaccine Safety Hub agreed, adding “The folks at the clinic level are extremely busy every day and year round, especially during flu season. I want them to be able to open emails and know I am already providing them with information they need to do their jobs at the highest level.”

While the safety of a vaccine is approved by the Food and Drug Administration, there are environmental factors that can play a role in maintaining vaccine safety such as the temperatures in which they are stored, according to Dutra, who has been an IHS since 2014. “We check refrigerators to ensure vaccines are stored appropriately within temperature ranges, are away from interior walls of the refrigerator, allowing for air flow and making sure that vaccine is properly rotated and not expired.”

Temperature plays a critical role in vaccine safety because it can make the product ineffective depending on the specific requirements of the vaccine. “When this vaccine freezes it permanently loses its potency and then you can’t use it anymore,” said immunization health care specialist David English of the Pacific Region Vaccine Safety Hub. “But a vaccine can get a lot warmer and still be viable and that’s the importance of why we’re doing this, to make sure we’re not using vaccine that’s been compromised and we want to identify those vaccines that are still good to use.” 

From conducting Continuous Quality Immunization Improvement Process (CQIIP) checks both in person and virtual on a regular basis with each immunization clinic within the MHS, the IHS ensures immunization standards are met. Although not considered inspections, the CQIIP is an opportunity to perform quality checks and recommend improvement processes within the MTFs. The CQIIP or virtual version known as VCQIIP can last 2 hours or as long as 6 hours, according to Dutra. “It depends on how the clinics may answer questions and how deeply you have to go to improve the overall program,” he said.

At the core of the IHS role is to educate and answer any questions on immunization safety and immunization policies, whether it be from the CDC, IHD, or policies within each branch of service to help streamline patient care. “The IHSs provide related training to all aspects of the immunization process from the people that administer the vaccine to their leadership,” said English. “And the primary reason we do this is we’re following the guidance from the CDC and of course the Joint Regulation on Immunizations.”

But at the end of the day, it’s all about patient safety. “We want to make sure the vaccine that is being delivered is both safe and effective,” said Dutra. “We are passionate about what we do, and we are doing our part to protect the war fighter and at the end of the day that is the bottom line.”

You also may be interested in...

DHA-PI 6025.34: Guidance for the DoD Influenza Vaccination Program (IVP)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), implements instructions, assigns responsibilities, and prescribes procedures for the DoD Northern Hemisphere (NH) and Southern Hemisphere (SH) Seasonal influenza vaccination program.

DHA IPM 20-002: Southern Hemisphere Influenza Vaccination Program

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), establishes the Defense Health Agency’s (DHA) procedures to implement instructions, assign responsibilities, and prescribe procedures for the Southern Hemisphere Influenza Vaccination Program. All Active Duty, Selected Reserve, and National Guard members receive an annual influenza vaccination. Personnel who are traveling to, conducting a permanent change of station to, or are located in the Southern Hemisphere will receive the Southern Hemisphere influenza vaccine or obtain an exemption (e.g., medical or administrative) in accordance with guidance in paragraph 6.a. of Attachment 2. Military personnel residing in the Southern Hemisphere who have received the Southern Hemisphere influenza vaccine in accordance with Appendix 1, meet the annual influenza immunization requirement.

DHA IPM 19-006: 2019–2020 Seasonal Influenza Vaccination Program (IVP)

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (o), implementing instructions, assigns responsibilities, and prescribes procedures for the seasonal influenza vaccination program. • This DHA-IPM cancels and reissues DHA-IPM 18-005. • This DHA-IPM is effective immediately and will expire 12 months from the date of issue.

DODI 6205.02 DOD Immunization Program

Policy

Establishes policy, assigns responsibilities, and provides procedures to establish a uniform DoD immunization program, in accordance with the authority in DoDD 6200.04 and DoD Instruction (DoDI) 1010.10.

Immunizations and Chemoprophylaxis for the Prevention of Infectious Diseases

Policy
  • Identification #: Army Regulation 40–562 BUMEDINST 6230.15B AFI 48–110_IP CG COMDTINST M6230.4G
  • Date: 10/7/2013
  • Type: Instructions
  • Topics: Immunization Healthcare

Guidance on Medications for Prophylaxis of Malaria 13-002

Policy

This document provides guidance and best practices for the chemoprophylaxis (use of medication to prevent malaria) of Service members serving in malaria endemic regions.

Clinical Policy for the Administration of the Anthrax Vaccine Adsorbed

Policy

Department of Defense Guidance Regarding Thimerosal Containing Vaccines

Policy

This memo provides guidance regarding the use of vaccines containing Thimerosal.

DoD Directive 6205.03: DoD Immunization Program for Biological Warfare Defense

Policy

Establishes policy, assigns responsibilities, and prescribes procedures for members of the DoD against validated biological warfare threats, and prioritization of research, development, testing, acquisition, and stockpiling of biological defense vaccines under reference.

Showing results 1 - 9 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.